Please login to the form below

Not currently logged in
Email:
Password:

Otmar Wiestler appointed to Bayer supervisory board

He replaces Klaus Kleinfeld

edit-Otmar-D-WiestlerGermany-based Bayer has appointed Otmar Wiestler to its supervisory board with immediate effect.

Since January 2004 Wiestler has been chairman of Bayer's management board and scientific director of the German cancer research centre in Heidelberg, Germany. He has also been chairman of the advisory committee and a member of the board of German Cancer Aid.

In addition to these roles, he served in the executive committee of the Helmholtz Association from 2007 to 2012.

Wiestler succeeds Klaus Kleinfeld, who left the position in September in order to concentrate on other office and honorary posts, some of which are located in the US.

In regards to the appointment, Werner Wenning, chairman of Bayer's supervisory board, said: “We would like to thank Mr Kleinfeld for our very successful and trusting cooperation. In Prof Wiestler we have found a competent successor with extensive scientific expertise.”

9th October 2014

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics